Santero Therapeutics (Private limited company)
Santero Therapeutics is a Belgian company registered with the Crossroads Bank for Enterprises under enterprise number 0765.790.155. It was founded on 29-03-2021. Its registered office is in Charleroi. Its main activity is: Scientific research and development. Its annual accounts for 2025 report equity of € 3 631 776 and a loss of € 2 145 592. These accounts report 11.9 full-time equivalents. Addrly gives it a financial health grade of B, on a scale from A (safest) to E (most at risk). It filed its annual accounts within the legal deadline for each of its last 4 financial years.
Information last updated on 17-10-2026.
Company information
Key figures of Santero Therapeutics
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
Profit / lossiWhat the period earned after taxes. A negative amount is a loss. | € -2 145 592+7 % | € -2 300 155-155 % | € -902 783-125 % | € -400 715 |
EquityiWhat belongs to the shareholders: capital contributed, reserves and profits kept in the company. | € 3 631 776+44 % | € 2 527 028+236 % | € 752 183+41 % | € 534 306 |
Total assetsiEverything the company owns. Equal to total equity and liabilities, which says how it is financed. | € 4 151 772+38 % | € 2 998 730+7 % | € 2 793 283+314 % | € 674 729 |
Gross marginiSales and other operating income, minus purchases of goods and services. What is left to pay the staff and everything else. | € 991 461+111 % | € 469 675+20 % | € 391 750 | € -74 756 |
Employees (FTE)iAverage number of workers over the period, in full-time equivalents. | 11.9+42 % | 8.4+147 % | 3.4+31 % | 2.6 |
Financial estimate
- 2 Shareholders
- 3 Board links
Similar companies
Other companies in the same activity in Charleroi.
| Company | Town |
|---|---|
| HENOGEN | 6041 Charleroi |
| ENDO TOOLS THERAPEUTICS | 6041 Charleroi |
| BIO.BE | 6041 Charleroi |
| OGECO | 6041 Charleroi |
| Brussels South Charleroi BioPark Dev | 6041 Charleroi |
| DNAVision | 6041 Charleroi |
| VIRIDAXIS | 6041 Charleroi |
| a-ULaB | 6041 Charleroi |
Frequently asked questions
Is Santero Therapeutics still active? Yes. The Crossroads Bank for Enterprises lists Santero Therapeutics as active.
What is the VAT number of Santero Therapeutics? The VAT number of Santero Therapeutics is BE 0765.790.155.
When was Santero Therapeutics founded? Santero Therapeutics was founded on 29-03-2021.
What is the address of Santero Therapeutics? The current registered office of Santero Therapeutics is Rue Clément Ader 10, 6041 Charleroi.
When did Santero Therapeutics last file annual accounts? The latest annual accounts of Santero Therapeutics were filed on 24-07-2026.
Does Santero Therapeutics file its annual accounts on time? Yes. Santero Therapeutics filed its annual accounts within the legal deadline for each of its last 4 financial years.
How many employees does Santero Therapeutics have? Santero Therapeutics employs 11.9 full-time equivalents according to its most recent annual accounts.
Is Santero Therapeutics financially healthy? Addrly gives Santero Therapeutics a financial health grade of B, on a scale from A (safest) to E (most at risk). The failure probability and the indicators behind it are visible with a free account.
Is Santero Therapeutics profitable? The annual accounts of Santero Therapeutics for 2025 show a loss of € 2 145 592.
What is the equity of Santero Therapeutics? The equity of Santero Therapeutics was € 3 631 776 at the close of the 2025 financial year.
Who are the directors of Santero Therapeutics? The annual accounts of Santero Therapeutics record 14 mandates. The names, roles and dates are visible with a free account.
Can Santero Therapeutics receive Peppol e-invoices? Yes. Santero Therapeutics is registered on the Peppol network and can receive structured electronic invoices.
What does Santero Therapeutics do? The main activity of Santero Therapeutics is: Scientific research and development.